2023
Delirium in older adults after percutaneous coronary intervention: Prevalence, risks, and clinical phenotypes
Park D, Jamil Y, Hu J, Lowenstern A, Frampton J, Abdullah A, Damluji A, Ahmad Y, Soufer R, Nanna M. Delirium in older adults after percutaneous coronary intervention: Prevalence, risks, and clinical phenotypes. Cardiovascular Revascularization Medicine 2023, 57: 60-67. PMID: 37414611, PMCID: PMC10730763, DOI: 10.1016/j.carrev.2023.06.010.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionHospital mortalityHigher oddsOlder adultsHospital deliriumCoronary interventionAdverse health-related outcomesInpatient percutaneous coronary interventionNon-home dischargePeri-procedural settingAcute kidney injuryImpact of deliriumPost-procedural complicationsNational Inpatient SampleHealth-related outcomesDelirium preventionHospital complicationsMore comorbiditiesGastrointestinal hemorrhageKidney injuryAdverse eventsSecondary outcomesBlood transfusionPrimary outcomeIntracranial hemorrhage
2021
Randomized Blinded Placebo-Controlled Trials of Renal Sympathetic Denervation for Hypertension: A Meta-Analysis
Ahmad Y, Kane C, Arnold AD, Cook CM, Keene D, Shun-Shin M, Cole G, Al-Lamee R, Francis DP, Howard JP. Randomized Blinded Placebo-Controlled Trials of Renal Sympathetic Denervation for Hypertension: A Meta-Analysis. Cardiovascular Revascularization Medicine 2021, 34: 112-118. PMID: 33551282, PMCID: PMC8813172, DOI: 10.1016/j.carrev.2021.01.031.Peer-Reviewed Original ResearchConceptsRenal denervationRelative risk reductionBlood pressureCatheter-based renal denervationMajor adverse cardiac eventsPlacebo-controlled trial dataAmbulatory diastolic blood pressureAmbulatory systolic blood pressurePlacebo-controlled randomized trialSystolic blood pressure changesOffice diastolic pressureRandomized blinded placeboAdverse cardiac eventsOffice blood pressurePlacebo-controlled trialPrimary efficacy outcomeDiastolic blood pressureRenal sympathetic denervationSystolic blood pressureBlood pressure changesRisk reductionCause mortalityEfficacy outcomesSympathetic denervationAdverse events
2018
Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis
Ahmad Y, Demir O, Rajkumar C, Howard JP, Shun-Shin M, Cook C, Petraco R, Jabbour R, Arnold A, Frame A, Sutaria N, Ariff B, Kanaganayagam G, Francis D, Mayet J, Mikhail G, Malik I, Sen S. Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis. Open Heart 2018, 5: e000748. PMID: 29387433, PMCID: PMC5786926, DOI: 10.1136/openhrt-2017-000748.Peer-Reviewed Original ResearchTranscatheter aortic valve implantationDual antiplatelet therapyAortic valve implantationAspirin monotherapyAntiplatelet therapyTAVI centresValve implantationBenefits of DAPTSystematic reviewOptimal antiplatelet strategyIncidence of strokeAntiplatelet useDAPT durationAdverse eventsAntiplatelet strategiesMedian durationInternational guidelinesMonotherapySuitable studiesTherapyElectronic surveyMetaregressionStrokeDeathDuration
2017
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, Keeble T, Mielewczik M, Kaprielian R, Malik IS, Nijjer SS, Petraco R, Cook C, Ahmad Y, Howard J, Baker C, Sharp A, Gerber R, Talwar S, Assomull R, Mayet J, Wensel R, Collier D, Shun-Shin M, Thom SA, Davies JE, Francis DP, investigators O, Al-Lamee R, Thompson D, Sen S, Tang K, Davies J, Keeble T, Kaprielian R, Malik I, Nijjer S, Petraco R, Cook C, Ahmad Y, Howard J, Shun-Shin M, Sethi A, Baker C, Sharp A, Ramrakha P, Gerber R, Talwar S, Assomull R, Foale R, Mayet J, Wensel R, Thom S, Davies J, Francis D, Khamis R, Hadjiloizou N, Khan M, Kooner J, Bellamy M, Mikhail G, Clifford P, O'Kane P, Levy T, Swallow R. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. The Lancet 2017, 391: 31-40. PMID: 29103656, DOI: 10.1016/s0140-6736(17)32714-9.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionPlacebo procedureExercise timeBiomedical Research CentrePlacebo groupPrimary endpointStable anginaCoronary interventionTrials of PCISingle-vessel stenosisMajor bleeding eventsSerious adverse eventsCardiopulmonary exercise testingDobutamine stress echocardiographySevere coronary stenosisInstantaneous wave-free ratioFractional flow reserveBleeding eventsPCI groupIschemic symptomsAdverse eventsExercise testingMedication optimizationAngina reliefRelated complications